Fractalkine

CX3CL1

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fractalkine, covering 2008-08-06 to 2008-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis